Skip to main content

Table 1 Characteristics of all head and neck squamous carcinoma (HNSCC) cell lines used in this pre-clinical study

From: Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts

Name

Sex

Age

Anatomical site

HPV status

FaDu

Male

56

Hypopharynx

HPV-negative

SAS

Female

69

Oral cavity (tongue)

HPV-negative

UT-SCC-5

Male

58

Oral cavity (tongue)

HPV-negative

UT-SCC-8

Male

42

Larynx

HPV-negative

CAL33

Male

69

Oral cavity (tongue)

HPV-negative

UT-SCC-45

Male

76

Oral cavity (floor of mouth)

HPV33-positive

SAT

Male

nd

Oral cavity

HPV-negative